- CLINICAL BRIEFINGS
Through comprehensive genomic and immune analyses, mechanisms of lung cancer resistance after treatment with EGFR inhibition and vaccine therapy were investigated. This case report, together with data from the longitudinal lung cancer study TRACERx, highlight the importance of understanding when targeted variants are acquired during the cancer’s evolutionary history.
light-sensitive cancer drugs win US$2 million contest
The winner of the Q4Bio US$2 million prize used the IBM Quantum System One computer, which is housed in the...
Huge analysis of 320,000 careers suggests that productive researchers stay that way
Credit: demaerre/iStock via GettyResearchers hoping to find late-career success are in for bad news. A study that tracked the publishing...
balancing two experiments at once
After reflecting on how the mid-career and midlife stages interact, Yu Tao developed several habits that he practises as a...
When page-renumbering causes outrage
Nature, Published online: 07 April 2026; doi:10.1038/d41586-026-00913-1The problem of page numbering in reprinted articles, and experiments to find the source...
